Path 7.5 Tablet
By Path
Rx
15 Tablet in a Strip

Composition
Pioglitazone(7.5mg)

Manufacturer - Lupin Ltd
Lupin Ltd, 3rd floor Kalpataru Inspire, Off. W E Highway, Santacruz (East), Mumbai 400 055. India

Expires on or after
July, 2026

liver
When taking Path 7.5 Tablet, it's important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment, so consulting your doctor before use is crucial. Avoid using Path 7.5 Tablet if you have severe liver disease to prevent any potential complications. Remember to discuss your liver health history with your healthcare provider before starting this medication.

kidney
Path 7.5 Tablet is safe for patients with kidney disease. Your doctor may adjust the dose, especially if you have a history of kidney conditions. No dose adjustment of Path 7.5 Tablet is recommended.

alcohol
For your safety, avoid consuming alcohol with Path 7.5 Tablet to prevent potential side effects.

driving
Path 7.5 Tablet typically does not impact your driving ability. However, be cautious if you notice any changes in your vision while using Piozar 7.5 Tablet 10's.

pregnancy
Path 7.5 Tablet is not recommended during pregnancy. Limited human studies and animal research suggest potential harm to the developing baby. Your doctor will evaluate the benefits versus risks before prescribing. Consult your doctor before using Path 7.5 Tablet during pregnancy.

breastfeeding
During breastfeeding, caution is advised when using Path 7.5 Tablet. It is recommended to wait until the mother's treatment is finished and the drug clears from her body. Monitor the baby's blood sugar while the mother is on Path 7.5 Tablet.
Habit Forming | No |
Chemical Class | Thiazolidinedione Derivative |
Therapeutic Class | ANTI DIABETIC |
Action Class | Thiazolidinedione(PPAR gamma agonist) |
₹94.65
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024